These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31708017)

  • 1. Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections.
    Abedon ST
    Adv Drug Deliv Rev; 2019 May; 145():18-39. PubMed ID: 31708017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.
    Bodier-Montagutelli E; Morello E; L'Hostis G; Guillon A; Dalloneau E; Respaud R; Pallaoro N; Blois H; Vecellio L; Gabard J; Heuzé-Vourc'h N
    Expert Opin Drug Deliv; 2017 Aug; 14(8):959-972. PubMed ID: 27776446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J; Park JH; Yong D
    BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii.
    Bagińska N; Pichlak A; Górski A; Jończyk-Matysiak E
    Virol Sin; 2019 Aug; 34(4):347-357. PubMed ID: 31093881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
    Maciejewska B; Olszak T; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage therapy of wound-associated infections.
    Zyman A; Górski A; Międzybrodzki R
    Folia Microbiol (Praha); 2022 Apr; 67(2):193-201. PubMed ID: 35028881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains.
    Chen LK; Kuo SC; Chang KC; Cheng CC; Yu PY; Chang CH; Chen TY; Tseng CC
    Sci Rep; 2017 Jul; 7(1):6319. PubMed ID: 28740225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Phage Therapy for Bone and Joint Infections.
    Ferry T
    Methods Mol Biol; 2024; 2734():207-235. PubMed ID: 38066372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro.
    Liu Y; Mi Z; Niu W; An X; Yuan X; Liu H; Wang Y; Feng Y; Huang Y; Zhang X; Zhang Z; Fan H; Peng F; Li P; Tong Y; Bai C
    Future Microbiol; 2016 Oct; 11():1383-1393. PubMed ID: 27538011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii.
    Yuan Y; Wang L; Li X; Tan D; Cong C; Xu Y
    Virus Res; 2019 Oct; 272():197734. PubMed ID: 31465789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again.
    Squires RA
    N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.
    Cisek AA; Dąbrowska I; Gregorczyk KP; Wyżewski Z
    Curr Microbiol; 2017 Feb; 74(2):277-283. PubMed ID: 27896482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring bacteriophage therapy for drug-resistant bacterial infections.
    Schooley RT
    Top Antivir Med; 2023 Mar; 31(1):23-30. PubMed ID: 37018733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.